Evaluation of the Chinese medicinal herb, Graptopetalum paraguayense, as a therapeutic treatment for liver damage in rat models

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Su, Li Jen ^a   Yang, Chih Hsueh ^b   Huang, Shiu Feng ^c   Yuo, Ya Ling ^c   Hsieh, Hui Chu ^d   Tseng, Tzu Ling ^d   Chen, Chang Han ^e   Hsu, Shih Lan ^f   Huang, Chi Ying F ^g  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLNITROSAMINE; EARLY GROWTH RESPONSE FACTOR 1; GRAPTOPETALUM PARAGUAYENSE EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; LIVER PROTECTIVE AGENT; NEU DIFFERENTIATION FACTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PLANT MEDICINAL PRODUCT; SILYMARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CHINESE MEDICINE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84864919701     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/256561     Document Type: Article

References (38)

1. Friedman S. L., Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury The Journal of Biological Chemistry 2000 275 4 2247 2250 (Pubitemid 30081976)
2. Prosser C. C., Yen R. D., Wu J., Molecular therapy for hepatic injury and fibrosis: where are we? World Journal of Gastroenterology 2006 12 4 509 515 (Pubitemid 43380778)
3. Iredale J. P., Cirrhosis: new research provides a basis for rational and targeted treatments British Medical Journal 2003 327 7407 143 147 (Pubitemid 36876209)
4. Saller R., Meier R., Brignoli R., The use of silymarin in the treatment of liver diseases Drugs 2001 61 14 2035 2063 (Pubitemid 33135182)
5. James O. F., D-penicillamine for primary biliary cirrhosis Gut 1985 26 2 109 113 (Pubitemid 15105134)
6. Jia J. D., Bauer M., Cho J. J., Ruehl M., Milani S., Boigk G., Riecken E. O., Schuppan D., Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen 1(I) and TIMP-1 Journal of Hepatology 2001 35 3 392 398 (Pubitemid 32844194)
7. Rui Y. C., Advances in pharmacological studies of silymarin Memorias do Instituto Oswaldo Cruz 1991 86 supplement 2 79 85
8. Stavinoha M. W., Soloway R. D., Current therapy of chronic liver disease Drugs 1990 39 6 814 840
9. Mavier P., Mallat A., Perspectives in the treatment of liver fibrosis Journal of Hepatology 1995 22 2 111 115
10. Friedman S. L., Seminars in medicine of the Beth Israel Hospital, Boston: the cellular basis of hepatic fibrosismechanisms and treatment strategies The New England Journal of Medicine 1993 328 25 1828 1835 (Pubitemid 23174715)
11. Lissoos T. W., Beno D. W., Davis B. H., Hepatic fibrogenesis and its modulation by growth factors Journal of Pediatric Gastroenterology and Nutrition 1992 15 3 225 231
12. Du B., You S., Present situation in preventing and treating liver fibrosis with TCM drugs Journal of Traditional Chinese Medicine 2001 21 2 147 152
13. Huang C. H., Horng L. Y., Chen C. F., Wu R. T., Chinese herb radix polygoni multiflori as a therapeutic drug for liver cirrhosis in mice Journal of Ethnopharmacology 2007 114 2 199 206
14. Shimizu I., Ma Y. R., Mizobuchi Y., Liu F., Miura T., Naka Y., Yasuda M., Shiba M., Horie T., Amagaya S., Kawada N., Hori H., Ito S., Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats Hepatology 1999 29 1 149 160 (Pubitemid 29023997)
15. Kusunose M., Qiu B., Cui T., Hamada A., Yoshioka S., Ono M., Miyamura M., Kyotani S., Nishioka Y., Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats Biological and Pharmaceutical Bulletin 2002 25 11 1417 1421 (Pubitemid 39663157)
16. Imanishi Y., Maeda N., Otogawa K., Seki S., Matsui H., Kawada N., Arakawa T., Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats Journal of Hepatology 2004 41 2 242 250 (Pubitemid 39177628)
17. Inao M., Mochida S., Matsui A., Eguchi Y., Yulutuz Y., Wang Y., Naiki K., Kakinuma T., Fujimori K., Nagoshi S., Fujiwara K., Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis Journal of Hepatology 2004 41 4 584 591 (Pubitemid 39297793)
18. Jézéquel A. M., Mancini R., Rinaldesi M. L., Macarri G., Venturini C., Orlandi F., A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat Journal of Hepatology 1987 5 2 174 181
19. Su L. J., Hsu S. L., Yang J. S., Tseng H. H., Huang S. F., Huang C. Y. F., Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: from pathological and biochemical data to microarray analysis Gene Expression 2006 13 2 107 132
20. Knodell R. G., Ishak K. G., Black W. C., Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1981 1 5 431 435 (Pubitemid 12218164)
21. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., Denk H., Desmet V., Korb G., MacSwen R. N. M., Phillips M. J., Portmann B. G., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Histological grading and staging of chronic hepatitis Journal of Hepatology 1995 22 6 696 699
22. Friedman S. L., Liver fibrosisfrom bench to bedside Journal of Hepatology 2003 38 supplement 1 S38 S53
23. Hayasaka A., Saisho H., Serum markers as tools to monitor liver fibrosis Digestion 1998 59 4 381 384 (Pubitemid 28360697)
24. Schuppan D., Krebs A., Bauer M., Hahn E. G., Hepatitis C and liver fibrosis Cell Death Differentiation 2003 10 supplement 1 S59 S67
25. Gressner A. M., Weiskirchen R., Breitkopf K., Dooley S., Roles of TGF-beta in hepatic fibrosis Frontiers in Bioscience 2002 7 d793 d807
26. Bauer M., Schuppan D., TGF 1 in liver fibrosis: time to change paradigms? FEBS Letters 2001 502 1-2 1 3 (Pubitemid 32722049)
27. Dooley S., Delvoux B., Streckert M., Bonzel L., Stopa M., Ten Dijke P., Gressner A. M., Transforming growth factor signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts: TGF signal transduction during transdifferentiation of hepatic stellate cells FEBS Letters 2001 502 1-2 4 10 (Pubitemid 32722050)
28. Zuberi S. J., Jafarey N. A., Lodi T. Z., Liver disease in hepatitis B antigen (HBAg) positive blood donors Journal of the Pakistan Medical Association 2004 54 8 S43 S45
29. Fiorucci S., Rizzo G., Antonelli E., Renga B., Mencarelli A., Riccardi L., Morelli A., Pruzanski M., Pellicciari R., Cross-talk between farnesoid-x-receptor (FXR) and peroxisome proliferator-activated receptor contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis Journal of Pharmacology and Experimental Therapeutics 2005 315 1 58 68 (Pubitemid 41380498)
30. Al-Shahrour F., Daz-Uriarte R., Dopazo J., FatiGO: a web tool for finding significant associations of gene ontology terms with groups of genes Bioinformatics 2004 20 4 578 580 (Pubitemid 38344339)
31. Ala-Kokko L., Pihlajaniemi T., Myers J. C., Kivirikko K. I., Savolainen E. R., Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat Biochemical Journal 1987 244 1 75 79 (Pubitemid 17098811)
32. Pan Q., Zhang Z. B., Zhang X., Shi J., Chen Y. X., Han Z. G., Xie W. F., Gene expression profile analysis of the spontaneous reversal of rat hepatic fibrosis by cDNA microarray Digestive Diseases and Sciences 2007 52 10 2591 2600 (Pubitemid 47373898)
33. Yin H. Q., Kim M., Kim J. H., Kong G., Kang K. S., Kim H. L., Yoon B. I., Lee M. O., Lee B. H., Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice Toxicology and Applied Pharmacology 2007 223 3 225 233 (Pubitemid 47371140)
34. Mazzocca A., Carloni V., Sciammetta S., Cordella C., Pantaleo P., Caldini A., Gentilini P., Pinzani M., Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration Journal of Hepatology 2002 37 3 322 330 (Pubitemid 34969948)
35. Seth D., Leo M. A., McGuinness P. H., Lieber C. S., Brennan Y., Williams R., Wang X. M., McCaughan G. W., Gorrell M. D., Haber P. S., Gene expression profiling of alcoholic liver disease in the baboon (papio hamadryas) and human liver American Journal of Pathology 2003 163 6 2303 2317 (Pubitemid 37466474)
36. Pritchard M. T., Nagy L. E., Ethanol-induced liver injury: potential roles for egr-1 Alcoholism: Clinical Experimental Research 2005 29 11, supplement 2 146S 150S (Pubitemid 43194342)
37. Jimenez W., Claria J., Arroyo V., Rodes J., Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease Journal of Gastroenterology and Hepatology 1992 7 1 90 97
38. Georgiev P., Jochum W., Heinrich S., Jang J. H., Nocito A., Dahm F., Clavien P. A., Characterization of time-related changes after experimental bile duct ligation British Journal of Surgery 2008 95 5 646 656